Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled Trial

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled Trial	central serous chorioretinopathy, eye disorder, retinal disorder	Not yet recruiting	Phase 2	2026-07-02		NCT07681167

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hoffmann-La Roche	280
Singapore National Eye Centre	21

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials